Navigation Links
Henry Schein to Present at the UBS 20th Annual Global Healthcare Services Conference
Date:2/4/2010

MELVILLE, N.Y., Feb. 4 /PRNewswire-FirstCall/ -- Henry Schein, Inc., (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, announced today that Stanley M. Bergman, Henry Schein's Chairman & Chief Executive Officer, and Steven Paladino, the Company's Executive Vice President and Chief Financial Officer, will present at the UBS 20th Annual Global Healthcare Services Conference on Monday, February 8, 2010.  The Conference is being held at the Grand Hyatt in New York City.  

Henry Schein's presentation is scheduled to begin at 3 p.m. ET and can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations" and following the link for "Webcasts."   A replay will be available on the Web site following the presentation.

About Henry Schein

Henry Schein, a Fortune 500® company and a member of the NASDAQ 100® Index, is the largest provider of health care products and services to office-based practitioners.  Recognized for its excellent customer service and highly competitive prices, the Company's four business groups – Dental, Medical, International and Technology – serve approximately 590,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions.  Henry Schein operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items.  Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.  

Headquartered in Melville, N.Y., Henry Schein employs more than 13,500 people and has operations or affiliates in 23 countries.  The Company's net sales reached a record $6.4 billion in 2008.  For more information, visit the Henry Schein Web site at www.henryschein.com.

SOURCE Henry Schein, Inc.

RELATED LINKS
http://www.henryschein.com

'/>"/>

SOURCE Henry Schein, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Henry Schein To Present At The Jefferies 2010 Global Healthcare Services Conference
2. Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors
3. Henry Schein Works With Supplier Partners to Earmark $1 Million in Health Care Supplies for Haiti Earthquake Relief
4. Henry Schein to Present at the NASDAQ OMX 23rd Investor Program
5. Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii
6. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
7. Pulse Systems Announces New Sales Representation in the Western United States
8. CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference
9. ADVENTRX Appoints Icahn Representative to Board of Directors
10. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
11. West to Present at UBS Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):